Christian T F, Behrenbeck T, Pellikka P A, Huber K C, Chesebro J H, Gibbons R J
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
J Am Coll Cardiol. 1990 Dec;16(7):1632-8. doi: 10.1016/0735-1097(90)90313-e.
Quantitation of perfusion defect size using tomographic imaging with technetium-99m-hexakis-2-methoxy isobutyl isonitrile was performed at the time of hospital discharge in 32 patients with a first myocardial infarction who underwent successful coronary reperfusion within 8 h of the onset of chest pain. Reperfusion was accomplished with thrombolysis or primary coronary angioplasty. Radionuclide angiography was performed at discharge and 6 weeks later. There was a close correlation between perfusion defect size and values for ejection fraction and regional wall motion both at discharge (r = -0.80 and -0.75, respectively) and 6 weeks later (r = -0.81 and -0.81, respectively). There was no overall group difference in ejection fraction between the value at discharge and at 6 weeks; however, five patients had a significant increase (greater than or equal to 0.08) and six had a significant decrease (greater than or equal to 0.08) in ejection fraction. In patients with a significant increase at 6 weeks, ejection fraction was significantly lower at discharge than the value predicted from perfusion defect size (0.37 +/- 0.09 measured versus 0.47 +/- 0.13 predicted, p less than 0.05) and it improved at 6 weeks to near predicted values (0.51 +/- 0.07). In patients with a significant decrease at 6 weeks, ejection fraction was significantly higher at discharge than the value predicted from perfusion defect size (0.60 +/- 0.10 measured versus 0.50 +/- 0.10 predicted, p less than 0.05) and it decreased at 6 weeks to near predicted levels (0.51 +/- 0.09). Left ventricular ejection fraction at the time of hospital discharge is a potentially misleading index of the efficacy of reperfusion therapy for myocardial infarction. In a significant minority (34%) of patients this index does not accurately reflect perfusion defect size, apparently because of the effects of myocardial stunning and compensatory hyperkinesia.
对32例首次发生心肌梗死且在胸痛发作8小时内成功进行冠状动脉再灌注的患者,在出院时采用锝-99m-六甲基异丁基异腈断层显像定量灌注缺损大小。再灌注通过溶栓或直接冠状动脉血管成形术完成。出院时及6周后进行放射性核素血管造影。出院时(分别为r = -0.80和-0.75)及6周后(分别为r = -0.81和-0.81),灌注缺损大小与射血分数及室壁运动值之间均存在密切相关性。出院时与6周时的射血分数总体组间差异无统计学意义;然而,5例患者射血分数显著增加(≥0.08),6例患者射血分数显著降低(≥0.08)。6周时射血分数显著增加的患者,出院时射血分数显著低于根据灌注缺损大小预测的值(实测值0.37±0.09对比预测值0.47±0.13,p<0.05),6周时改善至接近预测值(0.51±0.07)。6周时射血分数显著降低的患者,出院时射血分数显著高于根据灌注缺损大小预测的值(实测值0.60±0.10对比预测值0.50±0.10,p<0.05),6周时降低至接近预测水平(0.51±0.09)。出院时左心室射血分数对于心肌梗死再灌注治疗疗效而言可能是一个具有误导性的指标。在相当一部分(34%)患者中,该指标不能准确反映灌注缺损大小,显然是由于心肌顿抑和代偿性运动增强的影响。